Park, C.-W., Han, C.-T., Sakaguchi, Y., Lee, J., & Youn, H.-Y. (2020). The safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis. EXCLI Journal, 19, 187–200. https://doi.org/10.17179/excli2019-2058